Impact News +++ Idorsia sieht Licht am Ende des Tunnels (Cash) +++ IDORSIA Aktie +3,58%

EMBECTA Aktie

>EMBECTA Aktienkurs

9.35 EUR +0.0% (Tradegate)

Ask: 9.35 EUR / 640 Stück

Bid: 9.2 EUR / 660 Stück

Tagesumsatz: 9 Stück

Realtime Kurs von 8 bis 22 Uhr!

EMBECTA Aktie über LYNX handeln

Intraday

1 Jahr

>EMBECTA Performance

1 Woche: -8,2%

1 Monat: -2,1%

3 Monate: -29,3%

6 Monate: -28,2%

1 Jahr: -24,2%

laufendes Jahr: -51,5%

>EMBECTA Aktie

Name:

EMBECTA CORP. DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US29082K1051 / A3DGNE

Symbol/ Ticker:

JX7 (Frankfurt) / EMBC (NASDAQ)

Kürzel:

FRA:JX7, ETR:JX7, JX7:GR, NASDAQ:EMBC

Index:

Webseite:

https://www.embecta.com/

Marktkapitalisierung:

607.08 Mio. EUR

Umsatz:

953.53 Mio. EUR

EBITDA:

73.99 Mio. EUR

Gewinn je Aktie:

0.706 EUR

Schulden:

1386.15 Mio. EUR

Liquide Mittel:

184.79 Mio. EUR

Umsatz-/ Gewinnwachstum:

-9.8% / -18.7%

KGV/ KGV lG:

12.87 / -

KUV/ KBV/ PEG:

0.62 / - / -

Gewinnm./ Eigenkapitalr.:

4.89% / -

Dividende je Aktie:

0.559 EUR

Dividendenrendite/ -schätzung:

5.3% / 5.15%

Div. Historie:

28.02.25 - 0.14432€
06.12.24 - 0.14168€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

EMBECTA

Letzte Datenerhebung:

23.05.25

>EMBECTA Eigentümer

Aktien: 58.44 Mio. St.

f.h. Aktien: 57.24 Mio. St.

Insider Eigner: 0.4%

Instit. Eigner: 101.33%

Leerverk. Aktien: 5.05%

>EMBECTA Peer Group

ENHABIT

ICU MEDICAL

IMMUTEP ADR

INNATE PHARMA ADR

IRONWOOD

MAXCYTE

OMNICELL

PULSE BIOSCIENCES

ROCKWELL MEDICAL

XENCOR

>EMBECTA Chart & Kurs - NASDAQ

>EMBECTA News

22.05.25 - 12:33	embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day (GlobeNewswire EN)
	PARSIPPANY, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta"; "The Company") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host its inaugural Analyst and Investor Day today to showcase its phased approach for value creation and present its long range financial plan (“LRP”)....

09.05.25 - 19:48	Embecta raises adjusted EBITDA margin outlook for FY 2025 amid restructuring and debt reduction (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.05.25 - 18:45	Why Is Embecta Stock Falling On Friday? (Benzinga)
	Embecta reaffirms earnings outlook, trims revenue forecast, and boosts cash flow as restructuring and cost controls offset tariff and FX headwinds. read more...

09.05.25 - 15:00	Embecta Corp. (EMBC) Tops Q2 Earnings Estimates (Zacks)
	Embecta Corp. (EMBC) delivered earnings and revenue surprises of 6.06% and 2.92%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...

09.05.25 - 14:39	Embecta declares $0.15 dividend (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.05.25 - 13:18	Embecta reports FQ2 results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.05.25 - 12:33	Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results (GlobeNewswire EN)
	PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six month periods ended March 31, 2025....

09.05.25 - 12:03	embecta Announces Quarterly Cash Dividend (GlobeNewswire EN)
	PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company's common stock. The dividend is payable on June 13, 2025 to stockholders of record at the close of business on May 28, 2025....

28.04.25 - 13:33	Embecta to host Analyst and Investor Day on May 22, 2025 (GlobeNewswire EN)
	PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City....

21.04.25 - 23:03	embecta to Report Fiscal Second Quarter 2025 Financial Results (GlobeNewswire EN)
	PARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, May 9, 2025....

26.02.25 - 01:01	Insiderhandel: Aufsichtsrat kauft Aktien von Embecta im Wert von 177646 USD (Insiderkauf)
	Melcher, David F. - Aufsichtsrat - Tag der Transaktion: 2025-02-25...

18.02.25 - 23:03	embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference (GlobeNewswire EN)
	PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that Jake Elguicze, embecta's Chief Financial Officer, will present at the J.P. Morgan Global Leveraged Finance Conference in Miami on Tuesday, February 25, 2025 at 3:00 p.m. ET....

15.02.25 - 05:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Embecta im Wert von 50783 USD (Insiderkauf)
	Morris, Milton Mayo - Aufsichtsrat - Tag der Transaktion: 2025-02-13...

06.02.25 - 20:00	Embecta raises FY2025 adjusted EBITDA margin guidance to 37% amid cost-cutting and debt reduction focus (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.02.25 - 15:15	Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates (Zacks)
	Embecta Corp. (EMBC) delivered earnings and revenue surprises of 44.44% and 2.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?...

06.02.25 - 12:48	Embecta beats top-line and bottom-line estimates; updates FY24 outlook (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.02.25 - 12:33	Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire EN)
	PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month period ended December 31, 2024....

06.02.25 - 12:18	Embecta declares $0.15 dividend (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.02.25 - 12:03	embecta Announces Quarterly Cash Dividend (GlobeNewswire EN)
	PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company's common stock. The dividend is payable on March 14, 2025 to stockholders of record at the close of business on February 28, 2025....

23.01.25 - 23:03	embecta to Report Fiscal First Quarter 2025 Financial Results (GlobeNewswire EN)
	PARSIPPANY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal first quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, February 6, 2025....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Ein Hamsterrad schaut von innen aus wie eine Karriereleiter. - Roland Düringer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram